Differential expression of IL-10, IL-6, and TNF-α was not observed in the B. fragilis-treated group with DSS administration, a finding which is different from the reported role of B. fragilis in preventing inflammation in T-cell transfer or a TNBS-induced colitis model. This evidence concerns the gene IL6 and colitis.